What it sells
Personalized prevention using genetics and AI
Business model breakdown
Trigger: what makes them buy now?
High sequencing cost and bespoke software pipelines slowing timelines; site claims to cut sequencing costs by 50-90%.
Workflow: what inputs become what output?
Replace bespoke software pipelines with SaaS for population genetics and polygenic risk scoring to predict, detect and prevent disease.
Economics: what it saves and how it charges
SaaS technology plus community; claims 50%-90% reduction in sequencing costs. No prices.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2024 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.